CAREER
Alembic Pharma receives USFDA’s tentative approval for Alogliptin Tablet
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Alogliptin Tablets, 6.25 mg, 12.5 mg and…

